SynthesisFrontiers in immunology2025
Global research status and frontiers on ferroptosis in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis.
Synthesis in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiogenomics and machine learning in hepatocellular carcinoma: from foundations to clinical translation.World journal of surgical oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study was to analyze the research hotspots and future trends in the field of ferroptosis in hepatocellular carcinoma in the past 10 years by using bibliometrics and visualization software, and to provide reference for future research directions in this field. Methods: The Web of Science database was searched from January 1, 2012, to October 30, 2024, and the annual publication volume, countries, institutions, journals, authors, references, keywords, and other information in this field were analyzed by bibliometrics, VOSviewer, and CiteSpace. Results: A total of 645 English articles from 729 institutions in 32 countries were included in this study, with 4545 authors published in 261 journals. In the past three years, 518 articles were published, accounting for 80.3%. China has the most publications, followed by the United States. Frontiers in Oncology had the highest number of papers (n=26), while Cell had the highest number of citations (n=1206). The current research mainly focuses on two aspects: one is the study of the mechanism of ferroptosis to explore new therapeutic targets, and the other is the exploration of therapeutic methods, such as photodynamic therapy and nanomaterials, in order to inhibit the proliferation of tumor cells, reduce drug resistance, and enhance the efficacy by regulating ferroptosis, which may become a future development trend. Conclusion: In recent years, there have been increasing studies on the association between ferroptosis and hepatocellular carcinoma. This is the first comprehensive bibliometric study, which provides a reliable reference for future research in this field and promotes its further development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.